March 31, 2021
Sumitomo Dainippon Pharma said on March 30 that its wholly owned subsidiary Sumitovant Biopharma has completed a transaction announced last November to acquire the entire stake in Urovant Sciences. Sumitovant previously had a 75% stake in Urovant, a urinary disease...read more